GEN Exclusives

More »

GEN News Highlights

Back to Item »

Alder Earns $15M Milestone from BMS on the Start of Phase IIa Trial with IL-6-Targeting mAb

BMS-conducted rheumatoid arthritis study will evaluate the safety and efficacy of subcutaneous ALD518/BMS-945429.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Companion Animal Care

Do you think Americans spend too much on companion animal care?